DACLATASVIR plus ASUNAPREVIR VERSUS SOFOSBUVIR/LEDIPASVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 1 IN JAPANESE PATIENTS: A MATCHING-ADJUSTED INDIRECT COMPARISON

被引：0
|
作者：
Swallow, E. [1 ]
Kelley, C. [1 ]
Ristovska, L. [1 ]
Signorovitch, J. E. [1 ]
Kalsekar, A. [2 ]
Wygant, G. [2 ]
McPhee, F. [2 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Bristol Myers Squibb Pharmaceut Ltd, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1915
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN5
引用
收藏
页码：A576 / A576
页数：1
相关论文
共 50 条
  • [1] Daclatasvir plus asunaprevir versus sofosbuvir/ledipasvir for hepatitis C genotype 1 in Japanese patients: an indirect comparison
    Swallow, Elyse
    Kelley, Caroline
    Signorovitch, James
    Wygant, Gail
    McPhee, Fiona
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (03) : 273 - 279
  • [2] Daclatasvir plus sofosbuvir versus standard of care for hepatitis C genotype 3: a matching-adjusted indirect comparison
    Swallow, Elyse
    Song, Jinlin
    Yuan, Yong
    Kalsekar, Anupama
    Kelley, Caroline
    Mu, Fan
    Kim, Soomi
    Noviello, Stephanie
    Signorovitch, James
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (02) : 129 - 139
  • [3] COMPARATIVE EFFICACY AND TOLERABILITY OF DACLATASVIR plus SOFOSBUVIR VERSUS SOFOSBUVIR plus RIBAVIRIN FOR HEPATITIS C GENOTYPE 3: A MATCHING-ADJUSTED INDIRECT COMPARISON
    Swallow, E.
    Song, J.
    Yuan, Y.
    Kalsekar, A.
    Kelley, C.
    Mu, F.
    Kim, S.
    Noviello, S.
    Signorovitch, J.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S665 - S665
  • [4] Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect Comparison
    Swallow, Elyse
    Song, Jinlin
    Yuan, Yong
    Kalsekar, Anupama
    Kelley, Caroline
    Peeples, Miranda
    Mu, Fan
    Ackerman, Peter
    Signorovitch, James
    CLINICAL THERAPEUTICS, 2016, 38 (02) : 404 - 412
  • [5] Comparative Efficacy and Tolerability of Daclatasvir plus Sofosbuvir versus Sofosbuvir plus Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-Adjusted Indirect Comparison
    Swallow, Elyse
    Song, Jinlin
    Yuan, Yong
    Kalsekar, Anupama
    Kelley, Caroline
    Peeples, Miranda
    Mu, Fan
    Noviello, Stephanie
    Signorovitch, James
    HEPATOLOGY, 2015, 62 : 561A - 561A
  • [6] Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients
    Abdelaty, Lamiaa N.
    Elnaggar, Ahmed A.
    Said, Amira A.
    Hussein, Raghda R. S.
    CURRENT DRUG SAFETY, 2020, 15 (01) : 53 - 60
  • [7] Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy
    Iio, Etsuko
    Shimada, Noritomo
    Takaguchi, Koichi
    Senoh, Tomonori
    Eguchi, Yuichiro
    Atsukawa, Masanori
    Tsubota, Akihito
    Abe, Hiroshi
    Kato, Keizo
    Kusakabe, Atsunori
    Miyaki, Tomokatsu
    Matsuura, Kentaro
    Matsunami, Kayoko
    Shinkai, Noboru
    Fujiwara, Kei
    Nojiri, Shunsuke
    Tanaka, Yasuhito
    HEPATOLOGY RESEARCH, 2017, 47 (12) : 1308 - 1316
  • [8] Daclatasvir plus asunaprevir in the treatment of uremic patients with chronic hepatitis C genotype 1b infection Reply
    Martin, Paul
    Jadoul, Michel
    KIDNEY INTERNATIONAL, 2020, 97 (03) : 615 - 615
  • [9] Randomized comparison of daclatasvir plus asunaprevir versus telaprevir plus peginterferon/ribavirin in Japanese hepatitis C virus patients
    Kumada, Hiromitsu
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Toyota, Joji
    Karino, Yoshiyasu
    Chayama, Kazuaki
    Kawakami, Yoshiiku
    Fujiyama, Shigetoshi
    Ito, Takayoshi
    Itoh, Yoshito
    Tamura, Etsuko
    Ueki, Tomoko
    Ishikawa, Hiroki
    Hu, Wenhua
    McPhee, Fiona
    Linaberry, Misti
    Hughes, Eric
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (01) : 14 - 22
  • [10] Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature
    Haga, Yuki
    Kanda, Tatsuo
    Yasui, Shin
    Nakamura, Masato
    Ooka, Yoshihiko
    Takahashi, Koji
    Wu, Shuang
    Nakamoto, Shingo
    Arai, Makoto
    Chiba, Tetsuhiro
    Maruyama, Hitoshi
    Yokosuka, Osamu
    Takada, Nobuo
    Moriyama, Mitsuhiko
    Imazeki, Fumio
    Kato, Naoya
    ONCOTARGET, 2018, 9 (04): : 5509 - 5513
12345